World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 19 February 2015
Main ID:  NCT00557934
Date of registration: 13/11/2007
Prospective Registration: No
Primary sponsor: University Hospital Tuebingen
Public title: Right Ventricular Contractility Reserve Following Repair of Tetralogy of Fallot TOF-Cond
Scientific title: Evaluation of Right Ventricular Contractility Reserve Function During Dobutamine Stress in Patients Following Surgical Repair of Tetralogy of Fallot
Date of first enrolment: October 2007
Target sample size: 16
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT00557934
Study type:  Interventional
Study design:  Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic  
Phase:  N/A
Countries of recruitment
Germany
Contacts
Name:     Michael Hofbeck, MD
Address: 
Telephone:
Email:
Affiliation:  University Childrens Hospital, Department of Pediatric Cardiology
Key inclusion & exclusion criteria

Inclusion Criteria:

1. Corrected tetralogy of Fallot or other surgery with involvement of the pulmonary
valve, chronic pulmonary regurgitation, dilated right ventricle

2. Patient's age > 4 years

3. Routine cardiac catheterization clinically indicated for deciding therapeutic
treatment

4. Informed assent/consent of patients/parent.

Exclusion Criteria:

1. Pregnancy/breast feeding, women of child-bearing age without contraception.

2. Present participation, and/or participation in a clinical study during the last 4
weeks.

3. Illnesses or malfunctions, which exclude a participation in this study after decision
of the investigating physician.

4. Other medical, psychological or social circumstances which complicate a regular
participation in the study, and/or increase the risk for the patients themselves.



Age minimum: 4 Years
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Right Ventricular Dysfunction
Intervention(s)
Other: dobutamine
Primary Outcome(s)
Percentage of change of the maximal elastance (slope of the endsystolic pressure-volume relation)of the right ventricle following dobutamine infusion [Time Frame: 10 minutes after starting dobutamine infusion]
Secondary Outcome(s)
Brain natriuretic peptide [Time Frame: at cath study]
RV enddiastolic volume index (by MRI) [Time Frame: within the last 6 months before study]
Secondary ID(s)
Cond-07-1
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Fördergemeinschaft Deutsche Kinderherzzentren, Bonn, Germany
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history